共 54 条
- [11] Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis[J]. LANCET ONCOLOGY, 2010, 11 (08) : 753 - 762De Roock, Wendy论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumClaes, Bart论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium VIB, Louvain, Belgium Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium论文数: 引用数: h-index:机构:De Schutter, Jef论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumBiesmans, Bart论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumFountzilas, George论文数: 0 引用数: 0 h-index: 0机构: HeCOG, Thessaloniki, Greece Aristotle Univ Thessaloniki, Sch Med, GR-54006 Thessaloniki, Greece Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumKalogeras, Konstantine T.论文数: 0 引用数: 0 h-index: 0机构: HeCOG, Thessaloniki, Greece Aristotle Univ Thessaloniki, Sch Med, GR-54006 Thessaloniki, Greece Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumKotoula, Vassiliki论文数: 0 引用数: 0 h-index: 0机构: HeCOG, Thessaloniki, Greece Aristotle Univ Thessaloniki, Sch Med, GR-54006 Thessaloniki, Greece Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumPapamichael, Demetris论文数: 0 引用数: 0 h-index: 0机构: BO Cyprus Oncol Ctr, Nicosia, Cyprus Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumLaurent-Puig, Pierre论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, INSERM, UMR S775, Paris, France Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumPenault-Llorca, Frederique论文数: 0 引用数: 0 h-index: 0机构: Univ Auvergne, Dept Pathol, Ctr Lutte Canc Jean Perrin, Clermont Ferrand, France Univ Auvergne, Equipe Accueil EA 4233, Clermont Ferrand, France Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumRougier, Philippe论文数: 0 引用数: 0 h-index: 0机构: Hop Ambroise Pare, AP HP, Boulogne Billancourt, France Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumVincenzi, Bruno论文数: 0 引用数: 0 h-index: 0机构: Med Oncol Univ Campus Biomed Rome, Rome, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumSantini, Daniele论文数: 0 引用数: 0 h-index: 0机构: Med Oncol Univ Campus Biomed Rome, Rome, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumTonini, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: Med Oncol Univ Campus Biomed Rome, Rome, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumCappuzzo, Federico论文数: 0 引用数: 0 h-index: 0机构: Osped Civile, Div Med Oncol, Livorno, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumFrattini, Milo论文数: 0 引用数: 0 h-index: 0机构: Inst Pathol, Lab Mol Diagnost, Locarno, Switzerland Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumMolinari, Francesca论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumSaletti, Piercarlo论文数: 0 引用数: 0 h-index: 0机构: San Giovanni Hosp, Oncol Inst So Switzerland, Bellinzona, Switzerland Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumDe Dosso, Sara论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumMartini, Miriam论文数: 0 引用数: 0 h-index: 0机构: Univ Turin, Sch Med, Inst Canc Res & Treatment, Mol Genet Lab, Turin, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumBardelli, Alberto论文数: 0 引用数: 0 h-index: 0机构: Univ Turin, Sch Med, Inst Canc Res & Treatment, Mol Genet Lab, Turin, Italy Italian Fdn Canc Res, Inst Mol Oncol, Milan, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumSiena, Salvatore论文数: 0 引用数: 0 h-index: 0机构: Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumSartore-Bianchi, Andrea论文数: 0 引用数: 0 h-index: 0机构: Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumTabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Vall Hebron Univ Hosp, Dept Med Oncol, Barcelona, Spain Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumMacarulla, Teresa论文数: 0 引用数: 0 h-index: 0机构: Vall Hebron Univ Hosp, Dept Med Oncol, Barcelona, Spain Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumDi Fiore, Frederic论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, Rouen, France Fac Med, Inst Biomed Res, INSERM, U614, Rouen, France Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumGangloff, Alice Oden论文数: 0 引用数: 0 h-index: 0机构: Rouen Univ Hosp, Dept Hepatogastroenterol, Digest Oncol Unit, Rouen, France Fac Med, Inst Biomed Res, INSERM, U614, Rouen, France Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumCiardiello, Fortunato论文数: 0 引用数: 0 h-index: 0机构: Univ Naples 2, Dept Expt & Clin Med, Div Med Oncol, Naples, Italy Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumPfeiffer, Per论文数: 0 引用数: 0 h-index: 0机构: Odense Univ Hosp, Dept Oncol, Odense, Denmark Univ So Denmark, Inst Clin Res, Odense, Denmark Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium论文数: 引用数: h-index:机构:Hansen, Tine Plato论文数: 0 引用数: 0 h-index: 0机构: Odense Univ Hosp, Dept Pathol, Odense, Denmark Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumVan Cutsem, Eric论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Digest Oncol, Digest Oncol Unit, B-3000 Louvain, Belgium Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumPiessevaux, Hubert论文数: 0 引用数: 0 h-index: 0机构: UCL, Clin Univ St Luc, Serv Gastroenterol, Brussels, Belgium Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumLambrechts, Diether论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium VIB, Louvain, Belgium Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumDelorenzi, Mauro论文数: 0 引用数: 0 h-index: 0机构: Swiss Inst Bioinformat, Lausanne, Switzerland CHU Vaudois, Dept Format & Rech, Lausanne, Switzerland Katholieke Univ Leuven, Ctr Human Genet, Louvain, BelgiumTejpar, Sabine论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Digest Oncol, Digest Oncol Unit, B-3000 Louvain, Belgium Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium
- [12] Combine MEK inhibition with PI3K/mTOR inhibition exert inhibitory tumor growth effect on KRAS and PIK3CA mutation CRC xenografts due to reduced expression of VEGF and matrix metallopeptidase-9[J]. TUMOR BIOLOGY, 2015, 36 (02) : 1091 - 1097E, Jifu论文数: 0 引用数: 0 h-index: 0机构: Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R ChinaXing, Junjie论文数: 0 引用数: 0 h-index: 0机构: Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R ChinaGong, Haifeng论文数: 0 引用数: 0 h-index: 0机构: Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R ChinaHe, Jian论文数: 0 引用数: 0 h-index: 0机构: Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R ChinaZhang, Wei论文数: 0 引用数: 0 h-index: 0机构: Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai 200433, Peoples R China
- [13] Overcoming IGF1R/IR Resistance through Inhibition of MEK Signaling in Colorectal Cancer Models[J]. CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6219 - 6229Flanigan, Sara A.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USAPitts, Todd M.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USANewton, Timothy P.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USAKulikowski, Gillian N.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USATan, Aik Choon论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USAMcManus, Martine C.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Dept Pathol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USASpreafico, Anna论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USAKachaeva, Maria I.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USASelby, Heather M.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USATentler, John J.论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USAEckhardt, S. Gail论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USALeong, Stephen论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado Denver, Div Med Oncol, Aurora, CO USA Univ Colorado Denver, Div Med Oncol, Aurora, CO USA
- [14] From basic research to clinical development of MEK1/2 inhibitors for cancer therapy[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3Fremin, Christophe论文数: 0 引用数: 0 h-index: 0机构: Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, CanadaMeloche, Sylvain论文数: 0 引用数: 0 h-index: 0机构: Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada
- [15] The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition[J]. BRITISH JOURNAL OF CANCER, 2012, 106 (08) : 1386 - 1394Haagensen, E. J.论文数: 0 引用数: 0 h-index: 0机构: Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, EnglandKyle, S.论文数: 0 引用数: 0 h-index: 0机构: Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, EnglandBeale, G. S.论文数: 0 引用数: 0 h-index: 0机构: Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, EnglandMaxwell, R. J.论文数: 0 引用数: 0 h-index: 0机构: Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, EnglandNewell, D. R.论文数: 0 引用数: 0 h-index: 0机构: Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England Newcastle Univ, Newcastle Canc Ctr, No Inst Canc Res, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
- [16] PIK3CA Mutation Uncouples Tumor Growth and Cyclin D1 Regulation from MEK/ERK and Mutant KRAS Signaling[J]. CANCER RESEARCH, 2010, 70 (17) : 6804 - 6814Halilovic, Ensar论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA Cornell Univ, Weill Grad Sch Med Sci, Dept Pharmacol, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USAShe, Qing-Bai论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USAYe, Qing论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USAPagliarini, Raymond论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USASellers, William R.论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, Cambridge, MA USA Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USASolit, David B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USARosen, Neal论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA Cornell Univ, Weill Grad Sch Med Sci, Dept Pharmacol, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA
- [17] Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition[J]. CANCER RESEARCH, 2012, 72 (01) : 210 - 219Hoeflich, Klaus P.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USAMerchant, Mark论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USAOrr, Christine论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USAChan, Jocelyn论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USADen Otter, Doug论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USABerry, Leanne论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USAKasman, Ian论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USAKoeppen, Hartmut论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USARice, Ken论文数: 0 引用数: 0 h-index: 0机构: Exelixis Inc, San Francisco, CA USA Genentech Inc, San Francisco, CA 94080 USAYang, Nai-Ying论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USAEngst, Stefan论文数: 0 引用数: 0 h-index: 0机构: Exelixis Inc, San Francisco, CA USA Genentech Inc, San Francisco, CA 94080 USAJohnston, Stuart论文数: 0 引用数: 0 h-index: 0机构: Exelixis Inc, San Francisco, CA USA Genentech Inc, San Francisco, CA 94080 USAFriedman, Lori S.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USABelvin, Marcia论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Genentech Inc, San Francisco, CA 94080 USA
- [18] Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)[J]. CANCER RESEARCH, 2012, 72 (07) : 1804 - 1813Holt, Sarah V.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England Paterson Inst Canc Res, Drug Discovery Unit, Manchester M20 4BX, Lancs, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandLogie, Armelle论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandDavies, Barry R.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandAlferez, Denis论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandRunswick, Sarah论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandFenton, Sarah论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandChresta, Christine M.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandGu, Yi论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai, Peoples R China AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandZhang, Jingchuan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai, Peoples R China AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandWu, Yi-Long论文数: 0 引用数: 0 h-index: 0机构: Guang Dong Gen Hosp, Med Res Ctr, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandWilkinson, Robert W.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandGuichard, Sylvie M.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, EnglandSmith, Paul D.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England AstraZeneca, Oncol iMed, Macclesfield, Cheshire, England
- [19] Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling[J]. EMBO JOURNAL, 2008, 27 (14) : 1919 - 1931Ikenoue, Tsuneo论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USAInoki, Ken论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USAYang, Qian论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USAZhou, Xiaoming论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USAGuan, Kun-Liang论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
- [20] PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors[J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10 (03) : 558 - 565Janku, Filip论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USATsimberidou, Apostolia M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAGarrido-Laguna, Ignacio论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAWang, Xuemei论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USALuthra, Rajyalakshmi论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Mol Diagnost Lab, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAHong, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USANaing, Aung论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAFalchook, Gerald S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAMoroney, John W.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAPiha-Paul, Sarina A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAWheler, Jennifer J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAMoulder, Stacy L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAFu, Siqing论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAKurzrock, Razelle论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA